首页> 外文OA文献 >Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

【2h】

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

机译：糖蛋白IIb / IIIa抑制剂替罗非班对经皮冠状动脉介入治疗的患者磺达肝癸钠与依诺肝素的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Xin Zhao; Xiao-Xu Yang; Su-Zhen Ji; Xiao-Zeng Wang; Li Wang; Chong-Huai Gu; Li-Li Ren; Ya-Ling Han;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban [J] . Xin Zhao, Xiao-Xu Yang, Su-Zhen Ji, Military Medical Research . 2016,第1期

机译：糖蛋白IIb / IIIa抑制剂替罗非班对经皮冠状动脉介入治疗的患者磺达肝素与依诺肝素的疗效和安全性
2. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban [J] . Xin, Zhao, Xiao-Xu, 中国人民解放军军医大学学报：英文版 . 2016,第002期

机译：在糖蛋白IIB / IIIA抑制剂促甲铁邦治疗经皮冠状动脉介入的患者中FONDAPARINUX与烯诺拉帕林的疗效和安全性
3. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. [J] . Jolly SS, Faxon DP, Fox KA Journal of the American College of Cardiology . 2009,第5期

机译：磺达肝癸钠与依诺肝素对糖蛋白IIb / IIIa抑制剂或噻吩并吡啶治疗的急性冠脉综合征的疗效和安全性：来自OASIS 5（评估缺血性综合征策略的第五组织）试验的结果。
4. The Long-Term Clinical Outcomes of Platelet Glycoprotein Ilb/IIIa Inhibitor Combined with Low Molecular Weight Heparin in Patients with Acute Coronary Syndrome [C] . J.H. Kim, M.H. Jeong, Y.J. Hong, International Congress on Thrombosis . 2004

机译：血小板糖蛋白ILB / IIIa抑制剂的长期临床结果与急性冠状动脉综合征患者低分子量肝素联合
5. Meta-analysis: The impact of thrombectomy during PCI (percutaneous coronary intervention) on mortality, re-infarction and target vessel revascularization among patients with ST elevation myocardial infarction compared with standard PCI. [D] . Martar, Martar. 2016

机译：荟萃分析：与标准PCI相比，ST抬高型心肌梗死患者在PCI（经皮冠状动脉介入治疗）期间进行血栓切除术对死亡率，再梗塞和靶血管血运重建的影响。
6. Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban [O] . Xin Zhao, Xiao-Xu Yang, Su-Zhen Ji, 2016

机译：糖蛋白IIb / IIIa抑制剂替罗非班对经皮冠状动脉介入治疗的患者磺达肝癸钠与依诺肝素的疗效和安全性
7. Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial [O] . Jolly Sanjit S., Faxon David P., Fox Keith A.A., 2009

机译：Fondaparinux与依诺肝素对糖蛋白IIb / IIIa抑制剂或噻吩并吡啶治疗的急性冠脉综合征患者的疗效和安全性来自OASIS 5（评估缺血性综合征策略的第五组织）试验

Efficacy and safety of fondaparinux versus enoxaparin in patients undergoing percutaneous coronary intervention treated with the glycoprotein IIb/IIIa inhibitor tirofiban

著录项

相似文献

相关主题

期刊订阅